Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

FuturaGene unit in collaboration deal with Oregon State University

FuturaGene unit in collaboration deal with Oregon State University

FuturaGene PLC (AIM: FGN)  said its unit CBD Technologies Ltd has entered into a collaborative agreement with Oregon State University under which it will provide professor Steven Strauss’ research group at the Forest Biotechnology department with a proprietary eucalyptus clone and a highly efficient eucalyptus transformation protocol.

The collaboration will facilitate rapid and efficient evaluation of genes for flowering control and other biosafety aspects of tree modification.

In addition CBD Tech plans to join the Tree Biosafety and Genomics Research Cooperative (TBGRC), an internationally recognised tree research consortium that has been working with forest industries on tree biotechnology for 15 years and which is directed by Professor Strauss.

Although eucalyptus is the most widely planted commercial plantation tree species for pulp and paper production in the world, this species is notoriously difficult to transform, FurturaGene said in a statement.

Thus, the supply of a proprietary clone and transformation method from the company to a public research institute, under appropriate material usage and confidentiality provisions, represents a significant contribution to accelerating public research and development in this species, it added.



Register here to be notified of future FGN Company articles

Timeline

Related Articles

September 02 2014

ValiRx’s joint venture with Tangent Reprofiling, ValiSeek, has received a boost from the preclinical efficacy studies on its lead lung cancer treatment.

June 19
Collagen Solutions has set itself the goal of becoming a £100mln company in the next five years.
June 01
Silence Therapeutics has unveiled some highly encouraging early data that points to the efficacy of its treatment in patients with pancreatic cancer.

© Proactive Investors 2015